13.94MMarket Cap
LossP/E TTM
Lexaria Bioscience Corp's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Lexaria Bioscience Corp is 6.22, ranking 151 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -1.17, which is -49.44% below the recent high of -0.59 and -689.82% above the recent low of -9.28.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.